CEBP Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rossner, P.
Right arrow Articles by Santella, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rossner, P., Jr.
Right arrow Articles by Santella, R. M.
Cancer Epidemiology Biomarkers & Prevention Vol. 15, 639-644, April 2006
© 2006 American Association for Cancer Research

Relationship between Urinary 15-F2t-Isoprostane and 8-Oxodeoxyguanosine Levels and Breast Cancer Risk

Pavel Rossner, Jr.1,5, Marilie D. Gammon6, Mary Beth Terry2, Meenakshi Agrawal1, Fang Fang Zhang2, Susan L. Teitelbaum3, Sybil M. Eng4, Mia M. Gaudet6, Alfred I. Neugut2 and Regina M. Santella1

Departments of 1 Environmental Health Sciences, and 2 Epidemiology, Mailman School of Public Health, Columbia University; 3 Department of Community and Preventive Medicine, Mt. Sinai School of Medicine; 4 Pfizer, Inc., New York, New York; 5 Laboratory of Genetic Ecotoxicology, Health Institute of Central Bohemia and Institute of Experimental Medicine AS CR, Prague, Czech Republic; and 6 Department of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill, North Carolina

Requests for reprints: Regina M. Santella, Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY 10032. Phone: 212-305-1996; Fax 212-305-5328. E-mail: rps1{at}columbia.edu

To evaluate the role of oxidative stress in breast cancer, we measured urinary levels of 15-F2t-isoprostane (15-F2t-IsoP) and 8-oxodeoxyguanosine (8-oxodG) in 400 cases and 401 controls, participants of the Long Island Breast Cancer Study Project. We also analyzed the effect of different factors that are associated with oxidative stress and might influence 15-F2t-IsoP and 8-oxodG levels. We observed a statistically significant trend in breast cancer risk with increasing quartiles of 15-F2t-IsoP levels [odds ratio (OR), 1.25; 95% confidence interval (95% CI), 0.81-1.94; OR, 1.53; 95% CI, 0.99-2.35; OR, 1.88; 95% CI, 1.23-2.88, for the 2nd, 3rd, and 4th quartile relative to the lowest quartile, respectively; Ptrend = 0.002]. Although it is possible that increased levels may reflect the stress associated with recent treatment, the positive association was also observed when the analyses were restricted to case women for whom chemotherapy and radiation therapy had not yet been initiated at the time of the urine collection. The association with the highest quartile compared with lowest quartile of 15-F2t-IsoP was similar across strata of age, physical activity, fruit and vegetable intake, alcohol intake, cigarette smoking, body mass index, and menopausal status. We did not observe any association of breast cancer risk with 8-oxodG levels, but when cases with radiation treatment were removed from the analysis, a significant inverse trend (P = 0.04) was observed. Among controls, levels of 15-F2t-IsoP were higher among current cigarette smokers but did not differ by the amount of physical activity, fruit and vegetable intake, alcohol intake, body mass index, and menopausal status. Among controls, levels of 8-oxodG were higher among postmenopausal women and current and former cigarette smokers but did not differ by the other factors. In summary, our results suggest that urinary markers of lipid peroxidation and oxidative DNA damage may be associated with breast cancer risk. (Cancer Epidemiol Biomarkers Prev 2006;15(4):639-44)




This article has been cited by other articles:


Home page
CarcinogenesisHome page
H.-C. Wu, Q. Wang, H.-I Yang, H. Ahsan, W.-Y. Tsai, L.-Y. Wang, S.-Y. Chen, C.-J. Chen, and R. M. Santella
Urinary 15-F2t-isoprostane, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan
Carcinogenesis, May 1, 2008; 29(5): 971 - 976.
[Abstract] [Full Text] [PDF]


Home page
J Clin PharmacolHome page
L. S. Lee, S. D. Wise, C. Chan, T. L. Parsons, C. Flexner, and P. S. Lietman
Possible Differential Induction of Phase 2 Enzyme and Antioxidant Pathways by American Ginseng, Panax quinquefolius
J. Clin. Pharmacol., May 1, 2008; 48(5): 599 - 609.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. H. Schmitz, M. Warren, A. G. Rundle, N. I. Williams, M. D. Gross, and M. S. Kurzer
Exercise Effect on Oxidative Stress Is Independent of Change in Estrogen Metabolism
Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 220 - 223.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
J. Lin, J. E. Manson, J. Selhub, J. E. Buring, and S. M. Zhang
Plasma Cysteinylglycine Levels and Breast Cancer Risk in Women
Cancer Res., December 1, 2007; 67(23): 11123 - 11127.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
G. C. Kabat, A. B. Miller, M. Jain, and T. E. Rohan
Dietary Iron and Heme Iron Intake and Risk of Breast Cancer: A Prospective Cohort Study
Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1306 - 1308.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
H.-C. Wu, Q. Wang, L.-W. Wang, H.-I Yang, H. Ahsan, W.-Y. Tsai, L.-Y. Wang, S.-Y. Chen, C.-J. Chen, and R. M. Santella
Urinary 8-oxodeoxyguanosine, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan
Carcinogenesis, May 1, 2007; 28(5): 995 - 999.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 2006 by the American Association for Cancer Research.